Back
Expeditors International of Washington Vs. Novo Nordisk AS Industry Stock Comparison
Sell
21
EXPD
Expeditors International of Washington
Last Price:
$111.09
Seasonality Move:
5.76%
Sell
9
NONOF
Novo Nordisk AS
Last Price:
$83.81
Seasonality Move:
8.64%
Sell
21
Expeditors International of Washington (EXPD)
is a Sell
Is Expeditors International of Washington a Buy, Sell or Hold?
-
The current Expeditors International of Washington [EXPD] share price is $111.11. The Score for EXPD is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
EXPD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
9
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $83.81. The Score for NONOF is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
EXPD Stock Price Chart
What is Expeditors International of Washington's stock price today?
-
The Expeditors International of Washington share price today is $111.11Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EXPD is experiencing selling pressure, which indicates risk of future bearish movement.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $83.81Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing selling pressure, which indicates risk of future bearish movement.
EXPD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.5 | Sell |
Relative Strength Index (14 RSI): | 31.35 | Sell |
Chaikin Money Flow: | -784095 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (111.37 - 120.33) | Sell |
Bollinger Bands (100): | (116.24 - 124.46) | Sell |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.26 | Sell |
Relative Strength Index (14 RSI): | 29.14 | Sell |
Chaikin Money Flow: | -11150 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (88.64 - 110.9) | Sell |
Bollinger Bands (100): | (100.73 - 130.01) | Sell |
EXPD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 110.98 | Buy |
20-day SMA: | 114.51 | Sell |
50-day SMA: | 117.96 | Sell |
200-day SMA: | 120.17 | Sell |
8-day EMA: | 111.4 | Sell |
20-day EMA: | 113.77 | Sell |
50-day EMA: | 117.02 | Sell |
200-day EMA: | 119.72 | Sell |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 86.44 | Sell |
20-day SMA: | 97.55 | Sell |
50-day SMA: | 103.66 | Sell |
200-day SMA: | 124.08 | Sell |
8-day EMA: | 87.79 | Sell |
20-day EMA: | 94.23 | Sell |
50-day EMA: | 102.94 | Sell |
200-day EMA: | 115.31 | Sell |
Expeditors International of Washington Earnings Growth & EXPD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and an increase next year of $0.38 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Expeditors International of Washington Technical Analysis
Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |